RegenScientific - Cytophil, Inc. appoints Mr. Ron Renten as Vice President of Sales and Marketing for Aesthetics in Europe, the Middle East, and Africa

Fast growing RegenScientific strengthens its management team in preparation for commercial launch of its Renú® Soft Tissue Volumizing Implant in Europe, the Middle East, and Africa

Jan 12, 2016, 07:00 ET from RegenScientific

EAST TROY, Wis., Jan. 12, 2016 /PRNewswire/ -- RegenScientific announced today that Mr. Ron Renten has joined the company as Vice President of Sales and Marketing to launch and develop the market for its Renú® Soft Tissue Volumizing Implant in Europe, the Middle East, and Africa (EMEA). Mr. Renten will be based in Rotterdam, The Netherlands.

RegenScientific recently received the CE-mark for its Renú® (Calcium Hydroxyapatite) Soft Tissue Volumizing Implant indicated for facial lipoatrophy, soft tissue augmentation, and vocal fold insufficiency, and the company will launch this product for aesthetics medicine at the World Congress of the International Masters Course in Aesthetic Science (IMCAS) held on January 28-31, 2016 in Paris, France.

Mr. Renten most recently was a principal consultant at Netner Business Development BV, an aesthetic products consultancy specializing in EMEA distribution; previously he held sales and marketing management positions at BioForm Medical Europe BV (now part of Merz Pharmaceuticals, GmbH), Maxxim Medical Europe BV, and Inamed / McGhan Medical BV (now part of Allergan, Inc. / Activis, plc). He holds a Bachelor's Degree in Health Science from the Academy for Physiotherapy, The Hauge, Netherlands. Ron Renten said "I am excited to join the team at RegenScientific to develop the EMEA market for the Renú® product, and bring a cost-effective and long-lasting facial injectable implant to physicians and patients in Europe and the Middle East."

Mr. Charles Milo, MBA, Chief Business Officer said " We are thrilled to have Ron Renten join our management team, and we're excited about the launch of Renú® in Europe and the Middle East. Ron brings a wealth of experience in establishing and managing distribution organizations in Europe and the Middle East and I am certain that his experience will act as a springboard for our commercial launch of Renú®."

About RegenScientific- Cytophil, Inc.:

RegenScientific, a wholly-owned business unit of Cytophil, Inc., an ISO 13485 certified company, is dedicated to providing physicians and patients with high-quality, safe, efficacious, and cost-effective soft tissue augmentation implants. The company has CE-Mark for its Renú® Soft Tissue (Volumizing) Implant for lipoatrophy, vocal fold insufficiency, and soft tissue augmentation in Europe. The Company has FDA 510k clearances for its Renú® Gel and Renú® Voice otolaryngology products indicated for vocal fold injection augmentation.  Renú® is a registered trademark of Cytophil, Inc. REGENSCIENTIFIC™ and the REGENSCIENTIFIC logo are trademarks of Cytophil, Inc.

Contact RegenScientific - Cytophil, Inc.:

Charles F. Milo, MBA
Chief Business Officer
Tel: (262) 215-6779|
Email: cmilo@cytophil.com

Ron Renten
VP of Sales and Marketing, EMEA
Tel: +31 (0) 6 51 33 87 22
Email: rrenten@cytophil.com

Logo - http://photos.prnewswire.com/prnh/20150527/218707LOGO

 

SOURCE RegenScientific